Palisade Bio (PALI) Total Non-Current Liabilities (2016 - 2025)
Historic Total Non-Current Liabilities for Palisade Bio (PALI) over the last 14 years, with Q3 2025 value amounting to $3.5 million.
- Palisade Bio's Total Non-Current Liabilities rose 2963.1% to $3.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.5 million, marking a year-over-year increase of 2963.1%. This contributed to the annual value of $3.2 million for FY2024, which is 2415.64% up from last year.
- According to the latest figures from Q3 2025, Palisade Bio's Total Non-Current Liabilities is $3.5 million, which was up 2963.1% from $4.0 million recorded in Q2 2025.
- Over the past 5 years, Palisade Bio's Total Non-Current Liabilities peaked at $4.0 million during Q2 2025, and registered a low of $1.0 million during Q1 2021.
- Over the past 5 years, Palisade Bio's median Total Non-Current Liabilities value was $2.8 million (recorded in 2024), while the average stood at $2.8 million.
- Over the last 5 years, Palisade Bio's Total Non-Current Liabilities had its largest YoY gain of 38052.43% in 2021, and its largest YoY loss of 2326.37% in 2021.
- Quarter analysis of 5 years shows Palisade Bio's Total Non-Current Liabilities stood at $2.9 million in 2021, then grew by 6.3% to $3.1 million in 2022, then fell by 15.98% to $2.6 million in 2023, then rose by 24.16% to $3.2 million in 2024, then increased by 7.41% to $3.5 million in 2025.
- Its Total Non-Current Liabilities stands at $3.5 million for Q3 2025, versus $4.0 million for Q2 2025 and $2.8 million for Q1 2025.